This video examines the growing number of people diagnosed with anxiety disorder. It discusses the upcoming changes in the DSM-V that will set new definitions for anxiety disorders and investigates the role that pharmaceutical companies and the psychiatric profession play in this phenomenon.

Produced with the participation of CMF/FMC, the Ontario Film and Television Tax Credit, The Canadian Film or Video Production Tax Credit and The Rogers Documentary Fund.